Evidence map›Paper›PMID 21564097›Full record

ArticleJournal of neurochemistry2011

Casein kinase 1 enables nucleus accumbens amphetamine-induced locomotion by regulating AMPA receptor phosphorylation.

Dongdong Li, Stacy Herrera, Nancy Bubula, Elena Nikitina, Abraham A Palmer, Dorothy A Hanck, Jessica A Loweth, Paul Vezina

Open access · greenAbstract readComparative Study
In one paragraph

Article in Journal of neurochemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Neural plasticity · 2017
    Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Dongdong LiDepartment of Psychiatry and Behavioral Neuroscience, The University of Chicago, Chicago, Illinois 60637, USA.
Stacy Herrera
Nancy Bubula
Elena Nikitina
Abraham A Palmer
Dorothy A Hanck
Jessica A Loweth
Paul Vezina
University of Chicago · US

Funding

Sensitization and Stimulant Self-AdministrationR01DA009397 · NIDA · UNIVERSITY OF CHICAGO · PI VEZINA, PAUL R · 1995 to 2017
$4.0M
Systems Genetic Analysis of Methamphetamine's Motivational Effects in a Mouse AILR01DA021336 · NIDA · UNIVERSITY OF CHICAGO · PI PALMER, ABRAHAM A · 2006 to 2015
$4.0M
Viral-Mediated Alterations in CaMKII Alter Behavioral Responding to AmphetamineF31DA022834 · NIDA · UNIVERSITY OF CHICAGO · PI LOWETH, JESSICA ANNE · 2007 to 2008
$68k
NIDA NIH HHS F31 DA022834NIDA NIH HHS F31-DA-022834NIDA NIH HHS R01 DA009397NIDA NIH HHS R01 DA021336NIDA NIH HHS R01-DA-09397
6 · The paper itself

Abstract

The closely related δ and ε isoforms of the serine/threonine protein kinase casein kinase 1 (Csnk1) have been implicated in the generation of psychostimulant-induced behaviors. In this study, we show that Csnk1δ/ε produces its effects on behavior by acting on the Darpp-32-PP1 signaling pathway to regulate AMPA receptor phosphorylation in the nucleus accumbens (NAcc). Inhibiting Csnk1δ/ε in the NAcc with the selective inhibitor PF-670462 blocks amphetamine induced locomotion and its ability to increase phosphorylation of Darpp-32 at S137 and T34, decrease PP1 activity and increase phosphorylation of the AMPA receptor subunit at S845. Consistent with these findings, preventing GluR1 phosphorylation with the alanine mutant GluR1(S845A) reduces glutamate-evoked currents in cultured medium spiny neurons and blocks the locomotor activity produced by NAcc amphetamine. Thus, Csnk1 enables the locomotor and likely the incentive motivational effects of amphetamine by regulating Darrp-32-PP1-GlurR1(S845) signaling in the NAcc. As such, Csnk1 may be a critical target for intervention in the treatment of drug use disorders.

Indexed as

AmphetamineAnimalsCasein Kinase 1 epsilonCasein Kinase IdeltaGlutamic AcidMaleMotor ActivityNucleus AccumbensPhosphorylationProtein IsoformsRatsRats, Sprague-DawleyReceptors, AMPAAmphetamineCasein Kinase 1 epsilonCasein Kinase IdeltaGlutamic AcidProtein IsoformsReceptors, AMPA

Identifiers

PMID21564097
PMCPMC3129449
OpenAlexW2120525050

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.